CH557829A - Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten. - Google Patents

Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.

Info

Publication number
CH557829A
CH557829A CH802071A CH802071A CH557829A CH 557829 A CH557829 A CH 557829A CH 802071 A CH802071 A CH 802071A CH 802071 A CH802071 A CH 802071A CH 557829 A CH557829 A CH 557829A
Authority
CH
Switzerland
Prior art keywords
chinazolone
alkenyl
aryl
derivatives
alkyl
Prior art date
Application number
CH802071A
Other languages
German (de)
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH557829A publication Critical patent/CH557829A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH802071A 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten. CH557829A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH557829A true CH557829A (de) 1975-01-15

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH450174A CH569732A5 (OSRAM) 1970-06-05 1971-06-02

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH450174A CH569732A5 (OSRAM) 1970-06-05 1971-06-02

Country Status (10)

Country Link
US (1) US3984555A (OSRAM)
AT (3) AT318628B (OSRAM)
BE (1) BE768137A (OSRAM)
CA (1) CA951319A (OSRAM)
CH (3) CH557829A (OSRAM)
DE (1) DE2027645A1 (OSRAM)
FR (1) FR2100726B1 (OSRAM)
GB (1) GB1331522A (OSRAM)
LU (1) LU63267A1 (OSRAM)
NL (1) NL7107695A (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
DE69842109D1 (de) * 1997-08-21 2011-03-10 Shiseido Co Ltd Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
US6355637B1 (en) 1999-10-01 2002-03-12 Advanced Medicine, Inc. Local anesthetic compounds
RS51458B (sr) * 2000-04-25 2011-04-30 Icos Corporation Inhibitori humane fosfatidil-inozitol 3-kinaze delta
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
JP2005501887A (ja) * 2001-09-05 2005-01-20 ミナーヴァ・バイオテクノロジーズ・コーポレーション 癌の処置における組成物およびその使用
DE60236605D1 (de) 2001-09-05 2010-07-15 Minerva Biotechnologies Corp Zusammensetzungen und deren verwendung zur behandlung von krebs
JP2005511581A (ja) * 2001-11-07 2005-04-28 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害剤
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2004041755A2 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
DE602004022819D1 (de) * 2003-06-06 2009-10-08 Vertex Pharma Von atp-bindende kassette transportern
WO2005016348A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Method of inhibiting immune responses stimulated by an endogenous factor
WO2005016349A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Methods of inhibiting leukocyte accumulation
EP1761540B1 (en) 2004-05-13 2016-09-28 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
EP1755609A1 (en) * 2004-05-25 2007-02-28 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
WO2006089106A2 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
US8349850B2 (en) * 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2355828B1 (en) 2008-11-13 2018-05-30 Gilead Calistoga LLC Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
JP2012521994A (ja) 2009-03-24 2012-09-20 ギリアード カリストガ エルエルシー ２−プリニル−３−トリル−キナゾリノン誘導体のアトロプ異性体および使用方法
CN102458410A (zh) * 2009-04-20 2012-05-16 吉联亚·卡利斯托加有限责任公司 治疗实体瘤的方法
EA201270184A1 (ru) 2009-07-21 2012-08-30 ГИЛИЭД КАЛИСТОГА ЭлЭлСи Лечение расстройств печени ингибиторами pi3k
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
EP3581567A1 (en) * 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
AR090253A1 (es) 2012-03-05 2014-10-29 Gilead Calistoga Llc Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
ES2595240T3 (es) 2012-07-09 2016-12-28 Lupin Limited Derivados de tetrahidroquinazolinona como inhibidores de PARP
JP2017502021A (ja) 2013-12-20 2017-01-19 ギリアード カリストガ エルエルシー ホスファチジルイノシトール３−キナーゼ阻害剤のためのプロセス方法
CA2934534A1 (en) 2013-12-20 2015-06-25 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
SG11201609877XA (en) 2014-06-13 2016-12-29 Gilead Sciences Inc Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249281B (OSRAM) * 1963-05-18

Also Published As

Publication number Publication date
LU63267A1 (OSRAM) 1972-08-23
AT317899B (de) 1974-09-25
US3984555A (en) 1976-10-05
GB1331522A (en) 1973-09-26
FR2100726B1 (OSRAM) 1975-10-10
CH558374A (de) 1975-01-31
BE768137A (fr) 1971-12-06
DE2027645A1 (de) 1971-12-09
FR2100726A1 (OSRAM) 1972-03-24
CH569732A5 (OSRAM) 1975-11-28
NL7107695A (OSRAM) 1971-12-07
CA951319A (en) 1974-07-16
AT318628B (de) 1974-11-11
AT318615B (de) 1974-11-11

Similar Documents

Publication Publication Date Title
CH557829A (de) Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH550771A (de) Verfahren zur herstellung von phenaethylaminderivaten.
CH558353A (de) Verfahren zur herstellung von isoindolinderivaten.
CH550186A (de) Verfahren zur herstellung von 5-imino-1.2.4-triazin-derivaten.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH557349A (de) Verfahren zur herstellung von n-acylamino-pyrrolidinonderivaten.
CH550797A (de) Verfahren zur herstellung von tetrahydroisochinolinderivaten.
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
CH551984A (de) Verfahren zur herstellung von piperazinderivaten.
CH553185A (de) Verfahren zur herstellung von lumilysergol-derivaten.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH547261A (de) Verfahren zur herstellung von alkanolaminderivaten.
CH546810A (de) Verfahren zur herstellung von triarylmethanderivaten.
CH547802A (de) Verfahren zur herstellung von tetrahydropyridinderivaten.
CH555799A (de) Verfahren zur herstellung von cyclopropylmethylalkylaminen.
CH550809A (de) Verfahren zur herstellung von triazol-derivaten.
CH546782A (de) Verfahren zur herstellung von oxadiazolderivaten.
CH546243A (de) Verfahren zur herstellung von chinazolindion-derivaten.
CH557831A (de) Verfahren zur herstellung von triazolobenzodiazepin-5noxydderivaten.
CH557801A (de) Verfahren zur herstellung von 1,1,3-trialkoxy-2-cyanopropanen.
CH547771A (de) Verfahren zur herstellung von bornanaminderivaten.
CH548351A (de) Verfahren zur herstellung von 3-alkyl-5-tert.-butylphenolen.

Legal Events

Date Code Title Description
PL Patent ceased